News on Medial

Related News

Healthians achieves EBITDA breakeven with Rs 250 Cr income in FY24

EntrackrEntrackr · 1y ago
Healthians achieves EBITDA breakeven with Rs 250 Cr income in FY24
Medial

Diagnostic startup Healthians recorded a modest 8% year-on-year growth during the fiscal year ending March 2024. However, the WestBridge-backed company reduced its losses by 65% and achieved EBITDA breakeven in the same period. Healthians’s revenue from operations increased to Rs 243 crore in FY24 from Rs 224 crore in FY23, its consolidated annual results sourced from the Ministry of Corporate Affairs (MCA) show. Healthians offers at-home diagnostic services across over 250 cities and claims to have conducted more than 10 crore tests to date. Income from running laboratories for pathological tests was the primary source of revenue for Healthians which increased 8.62% to Rs 240.5 crore in FY24. The rest of the collections were from the sale of supplements, which stood at Rs 2.2 crore in the last fiscal year. Healthians also added Rs 10 crore from non-operational activities (interest income) which tallied the overall revenue to Rs 253 crore in FY24, as compared to Rs 236 crore in FY23. The Gurugram-based company allocated 40% of its overall burn to employee benefits. This cost dropped by 11.8% to Rs 120 crore in FY24 compared to Rs 136 crore in FY23. Advertising expenses also shrank over 62% to Rs 39 crore in FY24 from Rs 103 crore in FY23. The cost of material consumed, rent, Information technology, and other overheads took the overall expenditure to Rs 298 crore in FY24. The controlled spending on advertising and employee benefits helped Healthians to narrow losses by 65% to Rs 45 crore in FY24. With this, the company has achieved EBITDA breakeven in the previous fiscal (FY24). Coming to the ratios, Healthians’ ROCE and EBITDA margins improved to -20.4% and 0% (breakeven) in FY24. It spent Rs 1.23 to earn a rupee in FY24. The company has a total current assets of Rs 62 crore including the cash and bank balances of Rs 30 crore in the previous fiscal. Healthians has raised around $80 million to date including its last round of $54 million led by WestBridge in 2022. According to the startup data intelligence platform TheKredible, WestBridge is the largest external stakeholder with 25% followed by Beenext and DG Ventures. Financial stability is the primary thing that a company needs to survive. It seems like Healthians got some of the mantras to how to be constant with the scale while burning low. Achieving EBITDA breakeven for the first time will give more confidence to both founders and investors. Turning this achievement into net profits is difficult yet achievable- an approach Dr. PathLabs has been executing for many years. The next two to three years will be crucial in shaping the company's trajectory.

Healthians posts Rs 263 Cr revenue in FY25; nears breakeven

EntrackrEntrackr · 2m ago
Healthians posts Rs 263 Cr revenue in FY25; nears breakeven
Medial

Healthians posts Rs 263 Cr revenue in FY25; nears breakeven Healthians didn't manage notable growth in the fiscal year ending March 2025. However, the WestBridge-backed company narrowed its losses by 89% year on year and neared break-even during the same period. The firm’s operating revenue increased 8% year-on-year to Rs 263 crore in FY25, up from Rs 243 crore in FY24, as per its consolidated financial statements filed with the Registrar of Companies (RoC). Including non-operating income of Rs 7 crore, the company’s total income grew 7% to Rs 270 crore during the year. Cost optimisation played a key role in supporting the company’s financial recovery. Total expenses declined 8% to Rs 275 crore in FY25, compared to Rs 298 crore last year. Among the major cost heads, employee benefits, the largest expense category, dropped 13% year-on-year to Rs 104 crore in FY25 from Rs 120 crore in FY24. Cost of materials contracted 7% to Rs 54 crore. Advertising costs rose 10% to Rs 43 crore. Meanwhile, depreciation and finance costs remained stable at Rs 29 crore and Rs 15 crore, respectively. The improvement in revenue and control of key expenses helped Healthians bring down its losses sharply by 89% to Rs 5 crore in FY25 from Rs 45 crore in FY24. The firm posted positive EBITDA of Rs 32 crore in FY25 with EBITDA margin of 12.17%. Its ROCE stood at 2.73% in the same period. On a unit basis, the company spent Rs 1.05 to earn a rupee of operating revenue in FY25. The firm’s current assets increased slightly to Rs 170 crore including cash and bank balances worth Rs 49 crore in the fiscal. According to startup data intelligence platform TheKredible, Healthians has raised a total of $75 million of funding till date, having WestBridge, BEENEXT, DG Ventures and Youwecan as its lead investors. The company’s founder and CEO, Deepak Sahni owns 6.5% of the company.

Healthians founder Deepak Sahni steps down

EntrackrEntrackr · 11d ago
Healthians founder Deepak Sahni steps down
Medial

Snippets Healthians founder Deepak Sahni steps down Under Sahni’s leadership, Healthians has raised a total of 75 million dollars in funding to date, with WestBridge, BEENEXT, DG Ventures, and YouWeCan among its lead investors. Sahni owns 6.5 percent of the company. Gyan Vardhan 27 Jan 2026 14:06 IST Deepak Sahni, founder of health tech startup Healthians, has stepped down after a decade with the Gurugram-based company. “After spending 10 years as Founder and CEO of Healthians, I transitioned to the role of Executive Chairman in November 2023 and, over the past year, helped guide the company’s first truly professional management team. For me, Healthians will never be just a company. It has been a mission, a problem worth solving. After scaling it to a valuation of more than Rs 3,000 crore, expanding to over 300 cities, building more than 22 labs, and raising seven rounds of capital without external bankers, we have proven that diagnostics in India can be built at scale, with soul,” Sahni said in a LinkedIn post. Going forward, Sahni will focus on backing the next generation of founders through his 100 crore rupees corpus commitment. He plans to work on solving deeper problems in healthcare, support promising founders, and build new ventures with greater clarity and courage. He added that as of this month, he has stepped away from all formal executive responsibilities and will continue as a shareholder, cheering from the sidelines as the management team and investors take the company forward. Healthians’ operating revenue increased 8 percent year on year to Rs 263 crore in FY25 from Rs 243 crore in FY24, according to its consolidated financial statements filed with the Registrar of Companies. The company offers at home diagnostic services across more than 250 cities and claims to have conducted over 10 crore tests to date. Including non operating income of Rs 7 crore, Healthians’ total income grew 7% to Rs 270 crore during the year. Improved revenue and tighter cost controls helped Healthians reduce its losses sharply by 89% to Rs 5 crore in FY25 from Rs 45 crore in FY24. The firm also reported positive EBITDA of Rs 32 crore in FY25, with an EBITDA margin of 12.17%.

Download the medial app to read full posts, comements and news.